Market Tracker

04/27 5:16pm ET

Celgene Corp (NASDAQ:CELG)

During the Trading Day
114.72 -3.99 / -3.37%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
114.95 +0.2349 / +0.20%
 
Volume: 91.3K

Today’s Trading

Previous close118.71
Today’s open119.20
Day’s range114.31 - 119.38
Volume6,813,993
Average volume (3 months)5,489,541
Market cap$95.0B
Dividend yield--
Data as of 4:14pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.83%
Earnings growth (next 5 years)+23.49%
Revenue growth (last year)+17.89%
P/E ratio48.0
Price/Sales11.75
Price/Book14.56

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-1.03-1.43%
ABBVAbbVie-1.05-1.59%
BMYBristol-Myers Squibb-0.64-0.97%
LLYEli Lilly and Co-0.69-0.96%
Data as of 4:03pm ET, 04/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts